Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type
Open Access
- 5 February 2007
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 25 (7), 805-812
- https://doi.org/10.1111/j.1365-2036.2007.03268.x
Abstract
Summary Background Although Helicobacter pylori infection is closely associated with gastric cancer development, follow‐up studies after H. pylori eradication are still scarce. Aim To clarify the cancer preventive effect of H. pylori eradication, with special attention to differences in effect according to histology. Methods Patients who underwent H. pylori eradication therapy and were followed‐up endoscopically for at least 1 year were analysed. The incidence of gastric cancer and factors associated with cancer development were investigated. Results A total of 1807 patients were enrolled. Six of 1519 H. pylori eradicated and five of 288 persistent subjects developed gastric cancer. Four of the eradicated subjects developed the intestinal type and two the diffuse type, while four of the persistent subjects developed the intestinal type and one the diffuse type. Kaplan–Meier analysis indicated a significantly lower incidence in eradicated patients than in persistent patients. The incidence of intestinal type was significantly lower than in eradicated patients, while the diffuse type could not be evaluated because of the low incidence. Conclusions Helicobacter pylori‐eradicated patients had a reduced incidence of gastric cancer compared with H. pylori‐persistent patients, particularly the intestinal type, suggesting that H. pylori is strongly associated with intestinal‐type gastric cancer.Keywords
This publication has 25 references indexed in Scilit:
- Familial clustering in subgroups of gastric cancer stratified by histology, age group and locationEuropean Journal of Surgical Oncology, 2006
- Effects of Helicobacter pylori Eradication on Methylation Status of E-Cadherin Gene in Noncancerous StomachClinical Cancer Research, 2006
- Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylationGut, 2006
- Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 2005
- The −251T Allele of the Interleukin-8 Promoter Is Associated with Increased Risk of Gastric Carcinoma Featuring Diffuse-Type Histopathology in Chinese PopulationClinical Cancer Research, 2005
- Interleukin‐10 genotypes associate with the risk of gastric carcinoma in Taiwanese ChineseInternational Journal of Cancer, 2003
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Chemoprevention of Gastric Dysplasia: Randomized Trial of Antioxidant Supplements and Anti-Helicobacter pylori TherapyJNCI Journal of the National Cancer Institute, 2000
- Most Gastric Cancer Occurs on the Distal Side of the Endoscopic Atrophic BorderScandinavian Journal of Gastroenterology, 1999
- Gastric cancer risk in chronic atrophic gastritis: Statistical calculations of cross‐sectional dataInternational Journal of Cancer, 1985